Fact CheckerSign in

NCT07402863Completed

Self-Guided Resilience-Building Energy Management to Enhance Well-being (RENEW) Intervention for People With Systemic Sclerosis (SSc)

Self-Guided Resilience-Building Energy Management to Enhance Well-being Intervention for People With Systemic Sclerosis: A Feasibility Study

Source: ClinicalTrials.gov · Last updated 1 May 2026

Brief summary (registry, in English)

The goal of this clinical trial is to gather information on the RENEW app used by people with scleroderma. Specifically, the researchers want to learn more about RENEW by collecting information about the rates of recruitment, retention of study participants information about study completion, and time spent accessing the app content.

Status (registry)
Completed
Study type
Interventional
Enrollment
43 (actual)
First submitted
21 Jan 2026
Start date
28 Jan 2025
Primary completion date
28 Apr 2025
Lead sponsor
University of Michigan
NCT number
NCT07402863

What you commit to

  • Study type: Interventional
  • Participants enrolled: 43
  • From 28 Jan 2025 to the primary completion date, 28 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous experience with RENEW app or past participant of RENEW

Other

  • Complex, unstable health issues that would preclude full participation in the study
  • Planning to start new treatment for fatigue, pain, mood during the study period

Who the study is looking for

  • Have a diagnosis of systemic sclerosis including: diffuse cutaneous SSc, limited cutaneous SSc, overlap, or SINE
  • Have access to a reliable, internet-connected device (e.g. smartphone or tablet)
  • Be able to read, speak, and understand English
  • Participants need to report a score of at least 4 on a scale of 0 - 10 of fatigue severity, a cut-off for at least moderate fatigue in other fatiguing conditions1

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Michigan
Coordinator of this site? Confirm its status
Ann ArborUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.